Evidence map›Paper›PMID 41574433›Full record

ArticleNucleic acids research2026

An elevated level of the mRNA exporter Mex67-Mtr2 in nuclear mRNPs impairs nuclear mRNA export.

Nataliia Stefanyshena, Katja Sträßer

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nataliia StefanyshenaInstitute of Biochemistry, FB08, Justus Liebig University Giessen, Heinrich-Buff-Ring 17, 35392 Giessen, Germany.
Katja SträßerInstitute of Biochemistry, FB08, Justus Liebig University Giessen, Heinrich-Buff-Ring 17, 35392 Giessen, Germany.ORCID 0000-0003-3533-5516

Funding

Deutsche Forschungsgemeinschaft RTG 2355European Research Council 772049
6 · The paper itself

Abstract

In eukaryotes, nuclear messenger RNA (mRNA) export is a crucial step in gene expression, mediated by the conserved mRNA exporter Mex67-Mtr2 in Saccharomyces cerevisiae and NXF1-NXT1 in humans. Mex67-Mtr2 is recruited to the mRNA by the adaptors Hpr1, Nab2, Yra1, and Npl3, which play important yet incompletely understood roles in this process. Here, we uncover that, counterintuitively, an excess of Mex67 in nuclear messenger ribonucleoprotein particles (mRNPs) impairs nuclear mRNA export. Cells lacking Hpr1, which exhibit a nuclear mRNA export defect, show elevated levels of Nab2, Yra1, and Mex67 in nuclear mRNPs. Remarkably, overexpression of either Nab2 or Yra1 in Δhpr1 cells suppresses this export defect and simultaneously decreases the Mex67 level in nuclear mRNPs to those of wild-type cells. Importantly, a nuclear mRNA export defect is not inherently associated with an elevated Mex67 level in nuclear mRNPs, indicating that the increased Mex67 level in nuclear mRNPs of Δhpr1 cells is likely the cause rather than the consequence of the nuclear mRNA export defect. Thus, the precise regulation of the Mex67-Mtr2 level in nuclear mRNPs is essential for efficient nuclear mRNA export.

Indexed as

Cell NucleusNuclear ProteinsNucleocytoplasmic Transport ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA, MessengerRNA TransportSaccharomyces cerevisiae ProteinsActive Transport, Cell NucleusMembrane Transport ProteinsSaccharomyces cerevisiaeHPR1 protein, S cerevisiaeMembrane Transport Proteinsmessenger ribonucleoproteinMEX67 protein, S cerevisiaeMtr2 protein, S cerevisiaeNAB2 protein, S cerevisiaeNuclear ProteinsNucleocytoplasmic Transport ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA, MessengerSaccharomyces cerevisiae ProteinsYRA1 protein, S cerevisiae

Identifiers

PMID41574433
PMCPMC12828223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.